Yichao Chen

998 citations
35 papers · 842 indexed · h-index 18
Topics
Nanoparticle-Based Drug Delivery (14 papers)Nanoplatforms for cancer theranostics (11 papers)RNA Interference and Gene Delivery (6 papers)
Partner nations
United StatesChinaTaiwan

In The Last Decade

Yichao Chen

31 papers receiving 835 citations

Peers

Yichao Chen
Comparison fields: 5 of 97
  • Biomedical Engineering 386
  • Biomaterials 338
  • Molecular Biology 265
  • Immunology 236
  • Oncology 192
Replace Haishi Qiao with:
Haishi Qiao China
Binhua Zou China
Ka Hong Wong China
Yihua Yang China
Gyan Prakash India
Muhammad Kashif Riaz Hong Kong
Xue Shen China
Jianxia Dong China
Leilei Guo China
Yichao Chen relative to Haishi Qiao China Haishi Qiao's profile →
Citations per field
00.5×
Haishi Qiao · 1×
Citations per year

Countries citing papers authored by Yichao Chen

Since Specialization
Citations

This map shows the geographic impact of Yichao Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yichao Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yichao Chen more than expected).

Fields of papers citing papers by Yichao Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yichao Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yichao Chen. The network helps show where Yichao Chen may publish in the future.

Co-authorship network of co-authors of Yichao Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yichao Chen. A scholar is included among the top collaborators of Yichao Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yichao Chen. Yichao Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 1
5 0
6 1
7 1
8 1
9 4
10 41
11 41
12 31
13 28
14 14
15 97
16 33
17 17
18 169
19
Constitutive Model for Glassy-Active Phase Transformation on Shape Memory Polymers Considering Small Deformations
1
20 1

About Yichao Chen

Yichao Chen is a scholar working on Biomaterials, Biological Psychiatry and Immunology, having authored 35 papers that have together received 842 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (14 papers), Nanoplatforms for cancer theranostics (11 papers) and RNA Interference and Gene Delivery (6 papers). The work is most often cited by research in Biomaterials (338 citations), Biological Psychiatry (50 citations) and Immunology (236 citations). Yichao Chen has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Yixian Huang, Song Li, Wenchen Zhao, Raman Venkataramanan, Jingjing Sun, Binfeng Lu, Xiaolan Zhang, Yanhua Liu, Jieni Xu and Xiaochao Ma. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Journal of Controlled Release.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026